Printer Friendly

Articles from M2 Pharma (July 12, 2017)

1-34 out of 34 article(s)
Title Author Type Words
Accera signs strategic partnership and exclusive South Korea licensing agreement with DuChemBio. 178
Amgen's sBLA awarded US FDA for BLINCYTO to treat lymphoblastic leukemia. 293
Arena Pharmaceuticals Study of Ralinepag in Patients with Pulmonary Arterial Hypertension Shows Significant Improvement in Pulmonary Vascular Resistance. 352
AstraZeneca investing in Sydney manufacturing plant. 164
Bayer grants USD2m to 16 recipients across eight countries under BHAP in aid of haemophilia research and patient care. 238
Biocartis devices exempt from US FDA 510(k) notification requirements. 166
Biopharmaceutical Companies to Remain the Largest End-user of Chromatography Resins Globally, Future Market Insights Forecasts. 598
Copan Diagnostics Launches Fully Automated Instrument for Preparing Pour Plate Total Viable Counts. 244
DelMar Pharmaceuticals Names Zarrabian to Board, Mohr as Chair. 427
Enterome elects Mary Thistle to board. 119
ERYTECH Pharma forms research collaboration with Queen's University to develop treatment for arginase-1 deficiency. 228
FDA Grants Boston Biomedical Orphan Drug Designation for Cancer Peptide Vaccine in Myelodysplastic Syndrome. 270
First UK patients enrolled in Phase III ARTEMIS peanut allergy trial. 283
Global Pain Therapeutics Market to Reach USD 28.8bn by 2023, Research and Markets Forecasts. 290
HealthSouth to Change Named to Encompass Health in Rebranding Initiative. 295
InteliSyS elects Stanley Crane as CTO. 179
InteliSyS Health names new CTO. 210
International Consolidated Companies selects Premiere Elevations to license St James Remedies brand. 174
Kitov Pharmaceuticals anticipates USD3.5m from registered direct offering of ADS & warrants. 159
Locus Biosciences Raises USD 5m for CRISPR-Cas3 Antimicrobials. 247
Mendel.ai Secures USD 2m in Funding, Integrates with Comprehensive Blood and Cancer Center. 308
Nektar Presents Preclinical Data for Regulatory T Cell Stimulator at 13th World Congress of Inflammation. 420
Novarad App Used in First Surgery. 230
Orexo reports H1 2017 financial results. Financial report 130
Piedmont passes US FDA clearance for patented, pesticide-free RESULTZ Lice & Egg Elimination Kit. 250
Provention Bio elects Eleanor L. Ramos, MD as CMO & COO. 198
SeqLL Receives SBIR Grant for Direct RNA Sequencing Technology Development. 259
Stryker awarded US FDA approval for next generation radiofrequency ablation MultiGen 2 RF Generator. 239
The Broad Institute of MIT and Harvard discuss establishment of CRISPR-Cas9 joint licensing pool. 202
Twist Bioscience, Synbio Technologies Partner to Supply Long DNA to Customers. 233
Vifor Pharma announces three new clinical trials for Ferinject. 249
Wallace Named Chief Revenue Officer at PerfectServe. 223
Zimmer Biomet posts preliminary adjusted diluted earnings per share in USD2.08 to USD2.13 range for Q2 2017. Financial report 229
Zydus Cadila granted final FDA approval to commercialise Memantine Hydrochloride. 160

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |